4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-070697
Chief R&D Officer acquired 52,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zalevsky Jonathan Chief R&D Officer | 2021-12-16 | Grant or award | +52,950 | 285,034 | D | ||
| Derivatives | |||||||
| Zalevsky Jonathan Chief R&D Officer | 2021-12-16 | Grant or award · Stock Option | +94,000 | 94,000 | D | ||
Loading xslF345X03/doc4.xml…